Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,791 | -38,512 | -25,028 | -12,452 | -49,291 |
| Depreciation Amortization | 1,696 | 1,278 | 860 | 436 | 1,678 |
| Accounts payable and accrued liabilities | 168 | 1,024 | -59 | 985 | N/A |
| Other Working Capital | -1,331 | -1,628 | -2,939 | -413 | -1,269 |
| Other Operating Activity | 5,696 | 3,564 | 2,585 | 301 | 4,727 |
| Operating Cash Flow | $-45,562 | $-34,274 | $-24,581 | $-11,143 | $-44,155 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -441 | -178 | -178 | -15 | -678 |
| Investing Cash Flow | $-441 | $-178 | $-178 | $-15 | $-678 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -824 | -613 | -408 | -204 | N/A |
| Common Stock Issued | 76,466 | 33 | 2 | 2 | N/A |
| Other Financing Activity | -3,980 | -820 | -608 | 0 | 301 |
| Financing Cash Flow | $71,662 | $-1,400 | $-1,014 | $-202 | $301 |
| Beginning Cash Position | 40,004 | 40,004 | 40,004 | 40,004 | 84,536 |
| End Cash Position | 65,663 | 4,152 | 14,231 | 28,644 | 40,004 |
| Net Cash Flow | $25,659 | $-35,852 | $-25,773 | $-11,360 | $-44,532 |
| Free Cash Flow | |||||
| Operating Cash Flow | -45,562 | -34,274 | -24,581 | -11,143 | -44,155 |
| Capital Expenditure | -441 | -178 | -178 | -15 | N/A |
| Free Cash Flow | -46,003 | -34,452 | -24,759 | -11,158 | -44,155 |